How should mild gastritis identified on endoscopy be managed?

Management of Mild Gastritis Found on Endoscopy

For mild gastritis identified on endoscopy, test for Helicobacter pylori through gastric biopsies (which should have been obtained during the procedure), and if positive, treat with eradication therapy; if H. pylori-negative and symptomatic, use proton pump inhibitor (PPI) therapy for 4-8 weeks based on your predominant symptoms.

Immediate Next Steps

1. Determine H. pylori Status

Your endoscopy report should include biopsy results for H. pylori. If biopsies weren't taken, this represents a missed opportunity, as gastric biopsies should be obtained during endoscopy to document H. pylori status 1. The diagnosis of gastritis cannot rely on endoscopic appearance alone—studies show only 65% concordance between endoscopic and histologic findings 2, 3, meaning what looks like "mild gastritis" endoscopically may not correlate with the actual tissue diagnosis.

2. If H. pylori-Positive

Eradicate the infection regardless of symptom severity. The Maastricht consensus specifically recommends eradication for "gastritis with severe macro- or microscopic abnormalities" 4, though even mild gastritis warrants treatment as preventive medicine to reduce future risk of peptic ulcer disease and gastric cancer 1.

Recommended eradication regimen:

• Bismuth quadruple therapy for 14 days (preferred first-line when antibiotic susceptibility unknown) 5
• Alternative: PPI-based triple therapy for 7 days using a PPI plus two antibiotics (clarithromycin, metronidazole/tinidazole, or amoxicillin) 4

Post-treatment: Confirm eradication with a test-of-cure (urea breath test or stool antigen test) at least 4 weeks after completing therapy and stopping PPIs 6, 5.

3. If H. pylori-Negative and Symptomatic

Your treatment should be symptom-directed 1:

For ulcer-like symptoms (epigastric pain, burning):

• Full-dose PPI therapy for 4-8 weeks 1, 7
• This is first-choice therapy and confirms the acid-related nature of symptoms
• Examples: omeprazole 20-40 mg daily, lansoprazole 30 mg daily

For dysmotility-like symptoms (fullness, bloating, early satiety):

• Consider a prokinetic agent (though options are limited; cisapride is no longer recommended due to cardiac toxicity) 1
• If no response, switch to PPI therapy

After initial treatment course:

• Trial withdrawal of therapy 1
• Use on-demand therapy if symptoms recur
• If symptoms persist despite switching treatments, consider high-dose PPI therapy or re-evaluation 1

4. If H. pylori-Negative and Asymptomatic

No specific treatment is required. The finding of mild gastritis on endoscopy in an asymptomatic, H. pylori-negative patient does not mandate therapy. However, you should:

• Review for other causes: NSAID use, autoimmune gastritis (check for pernicious anemia if there are features of atrophic gastritis) 8
• Consider screening for celiac disease if biopsies weren't taken 8

Important Caveats

Endoscopic appearance is unreliable: Multiple studies demonstrate that endoscopy alone has poor diagnostic accuracy for gastritis (sensitivity 75%, specificity 63% for H. pylori-related gastritis) 9. The actual histologic diagnosis from your biopsies is what matters 2, 3, 10.

NSAID/aspirin use: If you're taking NSAIDs, erosions and peptic ulcers should not be accepted as the sole cause until H. pylori has been excluded and treated if present 8.

Atrophic gastritis or intestinal metaplasia: If your biopsy report mentions these findings (not just "mild gastritis"), this represents precancerous changes requiring different surveillance strategies, particularly in high-risk populations 6, 11, 12.

PPI considerations: If you were on PPIs before endoscopy, this can cause false-negative H. pylori tests. PPIs should ideally be stopped 10-14 days before testing 13, 6.

Follow-Up

• If treated for H. pylori: Test-of-cure is mandatory 5
• If symptomatic on PPI therapy: Continue until symptoms resolve, then attempt withdrawal
• No routine repeat endoscopy is needed for mild gastritis unless symptoms persist despite appropriate treatment or alarm features develop (weight loss, bleeding, progressive dysphagia) 7